Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-24 · accession 0001567619-23-003998 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-28 | 2023-02-24 | BMRN | Davis George Eric | EVP, CLO | M - OptEx | $67.81 | +1,474 | 56.7K | +3% | +$100.0K |
| D | 2023-02-28 | 2023-02-24 | BMRN | Davis George Eric | EVP, CLO | M - OptEx | $0.00 | -1,474 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-24 | M | A | 1,474 | $67.81 | 56,725 | D | — | — | |
| 2 | Derivative | Stock Option (Right to buy Common Stock) | 2023-02-24 | M | D | 1,474 | $0.00 | 0 | D | $67.81 · 2013-11-15 to 2023-05-14 | 1,474 Common Stock | (F1) Reflects the number of options outstanding after the transactions from this specific stock option grant. |